...
首页> 外文期刊>BMC Health Services Research >Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan
【24h】

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan

机译:台湾新诊断的无并发症高血压患者的降压药物处方模式和时间趋势

获取原文
           

摘要

Background Knowledge of existing prescription patterns in the treatment of newly-diagnosed hypertension can provide useful information for improving clinical practice in this field. The aims of this study are to determine the prescription patterns and time trends for antihypertensive medication in newly-diagnosed cases of uncomplicated hypertension in Taiwan and to compare these with current clinical guidelines. Methods A total of 6,536 newly-diagnosed patients with uncomplicated hypertension, aged ≥30 years, were identified from the representative 200,000-person sample in the computerized reimbursement database of the National Health Insurance in Taiwan. These patients were followed from 1998 to 2004 with all diagnoses, prescription data and medication charges being retrieved for subsequent analysis. Results Prescription patterns varied by age, gender and clinical facilities, with mono-therapies being found to be dominant in the first year, albeit declining over time. Calcium channel blockers and beta-blockers were the most frequently prescribed antihypertensive drugs, either alone or in combinations. Although least expensive, the prescription rates of diuretics were low, at 8.3% for mono-therapies and 19.9% overall. The prescription rate for angiotensin receptor blockers (ARBs) was elevated considerably over time. After controlling for other related factors by multiple logistic regression analysis, ARBs were found to be prescribed mainly by medical centers or regional hospitals. Conclusion These findings indicate the existence of a gap between current clinical practice and the desired goal of cost-effectiveness in antihypertensive treatment in Taiwan, which should be corrected.
机译:背景知识对新诊治的高血压的现有处方模式的了解可以为改善该领域的临床实践提供有用的信息。这项研究的目的是确定台湾新诊断的无并发症高血压病例的降压药物处方模式和时间趋势,并将其与当前的临床指南进行比较。方法从台湾国民健康保险的计算机化报销数据库中,从具有代表性的200,000人样本中识别出6,536名年龄≥30岁的新诊断的并发高血压患者。从1998年至2004年对这些患者进行随访,并检索所有诊断,处方数据和药物费用以进行后续分析。结果处方模式随年龄,性别和临床设施的不同而变化,第一年发现单一疗法占主导地位,尽管随时间而下降。钙通道阻滞剂和β受体阻滞剂是最常用的降压药,无论是单独使用还是组合使用。尽管最便宜,但利尿剂的处方率很低,单一疗法为8.3%,总体为19.9%。随着时间的推移,血管紧张素受体阻滞剂(ARBs)的处方率显着提高。通过多元逻辑回归分析控制其他相关因素后,发现ARB主要由医疗中心或地区医院开具。结论这些发现表明台湾目前的临床实践与抗高血压治疗的成本效益预期目标之间存在差距,应予以纠正。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号